Latest filing published 12 Apr 2023 for Pear Therapeutics, Inc., €1.4M. Read the official filing
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Filings by 5AM Partners IV, LLC span 2 companies, the busiest being Pear Therapeutics, Inc. and scPharmaceuticals Inc. The record holds 19 filings, for trades running from 11 April 2022 to 10 April 2023.
Sales make up the whole of the open-market record (19 sales, €7.0M). Since January 2023: no purchases and 1 sale on the market.
Most recently, on 12 April 2023, the filings show an open-market sale worth €1.4M in Pear Therapeutics, Inc. The median gap between a trade and its publication by SEC (Form 4) is 2 days. For comparison, the SEC allows two business days to file a Form 4. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
19 of 19 declarations